Clinical signifcance of annexin A1 expression in breast cancer

Journal of Breast Cancer

Volumn 14, Issue 4, 2011, Pages 262-268

  Yom, Cha Kyong ^a   Han, Wonshik ^b   Kim, Sung Won ^a   Kim, Hee Sung ^c   Shin, Hee Chul ^b   Chang, Ji Na ^d   Koo, Minyoung ^e   Noh, Dong Young ^b   Moon, Byung In ^d  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Electric Power Research Institute (KEPRI)   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e National Police Hospital   (South Korea)

Author keywords

Annexin A1; Breast neoplasms

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; LIPOCORTIN 1;

ADULT; ARTICLE; BREAST SURGERY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORE NEEDLE BIOPSY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL;

EID: 84863073621     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2011.14.4.262     Document Type: Article

References (21)

1. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, et al. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006;37:1583-91.
2. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002;82:331-71.
3. DAcquisto F, Paschalidis N, Sampaio AL, Merghani A, Flower RJ, Perretti M. Impaired T cell activation and increased T2 lineage commitment in Annexin-1 -defcient T cells. Eur J Immunol 2007;37:3131-42.
4. Croxtall JD, Flower RJ. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad SciUSA 1992;89:3571-5.
5. Lozano JJ, Silberstein GB, Hwang S, Haindl AH, Rocha V. Developmental regulation of calcium-binding proteins (calelectrins and calpactin I) in mammary glands. J Cell Physiol 1989;138:503-10.
6. Horlick KR, Ganjianpour M, Frost SC, Nick HS. Annexin-I regulation in response to suckling and rat mammary cell diferentiation. Endocrinology 1991;128:1574-9.
7. Creutz CE, Kambouris NG, Snyder SL, Hamman HC, Nelson MR, Liu W, et al. Effects of the expression of mammalian annexins in yeast secretory mutants. J Cell Sci 1992;103(Pt4):1177-1192.
8. Shen D, He J, Chang HR. In silico identifcation of breast cancer genes by combined multiple high throughput analyses. Int J Mol Med 2005; 15:205-12.
9. Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, et al. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun 2005;326: 218-27.
10. Zokas L, Glenney JR. Te calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: studies using monoclonal antibodies to calpactin subunits. J Cell Biol 1987;105:2111-21.
11. Glenney J, Zokas L. Antibodies to the N-terminus of calpactin II (p35) afect Ca2+ binding and phosphorylation by the epidermal growth factor receptor in vitro. Biochemistry 1988;27:2069-76.
12. Wood GS, Warnke R. Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J His-tochem Cytochem 1981;29:1196-204.
13. Man YG, Sang QX. Te signifcance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. Exp Cell Res 2004;301:103-18.
14. Alldridge LC, Harris HJ, Plevin R, Hannon R, Bryant CE. Te annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J Biol Chem 1999;274:37620-8.
15. Alldridge LC, Bryant CE. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 2003; 290:93-107.
16. Bastian BC. Annexins in cancer and autoimmune diseases. Cell Mol Life Sci 1997;53:554-6.
17. Pencil SD, Toth M. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma. Clin Exp Metastasis 1998;16:113-21.
18. Ahn SH, Sawada H, Ro JY, Nicolson GL. Diferential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis 1997;15:151-6.
19. Cicek M, Samant RS, Kinter M, Welch DR, Casey G. Identifcation of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Clin Exp Metastasis 2004;21:149-57.
20. Babbin BA, Lee WY Parkos CA, Winfree LM, Akyildiz A, Perretti M, et al. Annexin I regulates SKCO-15 cell invasion by signaling through for-myl peptide receptors. J Biol Chem 2006;281:19588-99.
21. Wang Y Serfass L, Roy MO, Wong J, Bonneau AM, Georges E. Annexin-I expression modulates drug resistance in tumor cells. Biochem Biophys Res Commun 2004;314:565-70.